MyFinsight
Home
Blog
About
Contact
Download
Download image
Maturities of marketable
securities
$284,000K
Proceeds from exercise of
stock options and espp
$30,313K
Net cash provided by
investing activities
$265,520K
Net cash provided by
financing activities
$29,514K
Canceled cashflow
$18,480K
Canceled cashflow
$799K
Net increase
(decrease) in cash and cash...
$71,743K
Canceled cashflow
$223,291K
Payment of az milestone
$15,000K
Purchase of fixed assets
$3,480K
Stock-based compensation
expense
$45,754K
Prepaid expenses and
other current assets
-$12,594K
Royalty financing
non-cash interest...
$5,114K
Depreciation
$2,934K
Amortization of intangible
assets
$2,081K
Amortization of debt issuance
costs
$1,382K
Finance lease
amortization expense
$678K
Non-cash operating lease
expense
$567K
Payments of finance lease
principal
$799K
Net cash used in
operating activities
-$222,738K
Effect of exchange
rates on cash and cash...
-$553K
Canceled cashflow
$71,104K
Change in fair value of
contingent consideration
-$228,914K
Other segment items
-$187,787K
R&d compensation
and...
-$101,624K
Sg&a compensation
and...
-$93,650K
Research and
development-Other
-$60,429K
Research and
development-Brensocatib
-$55,092K
Interest expense
-$43,114K
Cost of product
revenues (excluding...
-$31,298K
Research and
development-ARIKAYCE
-$23,716K
Research and
development-TPIP
-$21,215K
Depreciation
-$3,891K
Provision for income taxes
-$2,010K
Amortization of intangible
assets
-$1,983K
Net loss
-$163,563K
Change in fair value of
contingent consideration
-$46,961K
Accounts receivable
$38,190K
Canceled cashflow
$854,723K
Accounts payable and
accrued liabilities
-$33,875K
Accretion of discount on
marketable securities, net
$6,513K
Other assets
$2,357K
Inventory
$1,886K
Other liabilities
-$497K
something is missing
-$948,290K
Product revenues, net
-$36,616K
Investment income
-$33,380K
Back
Back
Cash Flow
source: myfinsight.com
INSMED Inc (INSM)
INSMED Inc (INSM)